Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer.
Journal: Cancers
Published: March 04, 2024
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer.
Journal: Cancer research communications
Published: May 07, 2023
HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: March 14, 2022
Integrated multiomic predictors for ovarian cancer survival.
Journal: Carcinogenesis
Published: May 02, 2017
CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer.
Journal: Oncotarget
Published: August 11, 2016
The Effect of Young Age in Hormone Receptor Positive Breast Cancer.
Journal: BioMed research international
Published: April 03, 2015
Combined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast cancer.
Journal: International journal of proteomics
Published: July 21, 2014
The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR.
Journal: Nature
Published: October 03, 2012
Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.
Journal: Journal of proteome research
Published: September 01, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026